Journament

Keyword Connections - drug discovery Keywords

Connection Type	Connection
Journals	Organic letters European journal of medicinal chemistry Marine drugs Pharmaceuticals (Basel, Switzerland) Bioorganic chemistry PeerJ International journal of molecular sciences The Journal of organic chemistry Journal of medicinal chemistry Chemistry (Weinheim an der Bergstrasse, Germany) Analytical chemistry ChemMedChem Briefings in bioinformatics Rapid communications in mass spectrometry : RCM analytical biochemistry ACS infectious diseases Nature journal of cellular biochemistry Cell reports structure (london, england : 1993) expert opinion on drug discovery clinical pharmacology and therapeutics omics : a journal of integrative biology the american journal of cardiology Archives of oral biology the american journal of occupational therapy : official publication of the american occupational therapy association Aging Metabolites current protocols in stem cell biology Circulation current protocols in bioinformatics the journal of pharmacology and experimental therapeutics kathmandu university medical journal (kumj)
Research Groups	No Research Group Connected
Bibliographies	[1] In vivo evaluation of isoprenoid triazole bisphosphonate inhibitors of geranylgeranyl diphosphate synthase: impact of olefin stereochemistry on toxicity and biodistribution. [2] Exploration of Pd-catalysed four-component tandem reaction for one-pot assembly of pyrazolo[1,5-c]quinazolines as potential EGFR inhibitors. [3] acute toxicity evaluation and molecular mechanism study of antiproliferative activity of a novel indole Schiff base -diiminato manganese complex in hormone-dependent and triple negative breast cancer cells. [4] A novel molecular representation with BiGRU neural networks for learning atom. [5] Developing tool and Measuring Integration Characteristics of Basic Science Curriculum to Improve Curriculum Integration. [6] Latest advances in aging research and drug discovery. [7] A Deep Learning Model for Cell Growth Inhibition IC50 Prediction and Its Application for Gastric Cancer Patients. [8] Plakinamine P, A Steroidal Alkaloid with Bactericidal Activity against . [9] How to Illuminate the Druggable Genome Using Pharos. [10] Metabolomics in the Context of Plant Natural Products Research: From Sample Preparation to Metabolite Analysis. [11] Challenges in Alzheimer Disease Drug Discovery and Development: The Role of Modeling, Simulation and Open Data. [12] Future challenges with DNA-encoded chemical libraries in the drug discovery domain. [13] Synthesis and Bioactivity of Phthalimide Analogs as Potential Drugs to Treat Schistosomiasis, a Neglected Disease of Poverty. [14] It Is Time to Revitalize the Antibiotic Pipeline: Systems Ecology Can Help. [15] XFEL and NMR Structures of Francisella Lipoprotein Reveal Conformational Space of Drug Target against Tularemia. [16] In vitro assessment of 3-alkoxy-5-nitroindazole-derived ethylamines and related compounds as potential antileishmanial drugs. [17] Dozens of coronavirus drugs are in development - what happens next? [18] Molecular docking and in silico studies of the physicochemical properties of potential inhibitors for the phosphotransferase system of Streptococcus mutans. [19] Clinical and Echocardiographic Predictors of Outcomes in Patients With Pulmonary Hypertension. [20] new small-molecule drug design strategies for fighting resistant influenza a [21] a qsar approach for virtual screening of lead-like molecules en route to antitumor and antibiotic drugs from marine and microbial natural products [22] mix-and-diffuse serial synchrotron crystallography [23] innovating chinese herbal medicine: from traditional health practice to scientific drug discovery [24] the promise and challenge of induced pluripotent stem cells for cardiovascular applications [25] nanoherbals in human healthcare: a proposed research and development roadmap i [26] from mollusks to medicine: a venomics approach for the discovery and characterization of therapeutics from terebridae peptide toxins [27] the process and strategy for developing selective histone deacetylase 3 inhibitors [28] functional rescue of f508del-cftr using small molecule correctors [29] molecular docking and structure-based drug design strategies [30] analytical and experimental pharmacology, challenges ahead [31] maximum entropy in drug discovery [32] mapping protein–protein interactions of the resistance-related bacterial zeta toxin–epsilon antitoxin complex (ε2ζ2) with high affinity peptide ligands using fluorescence polarization [33] the traditional medicine and modern medicine from natural products [34] role and regulation of glutathione metabolism in plasmodium falciparum [35] A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells. [36] Holocene carbon-cycle dynamics based on CO2 trapped in ice at Taylor Dome, Antarctica [37] A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen). [38] Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer's Disease. [39] One-Pot Transformation of Hypervalent Iodines into Diversified Phenoxazine Analogues as Promising Photocatalysts. [40] Synthesis and Structure-Activity Relationship Studies of Benzo[b][1,4]oxazin-3(4H)-one Analogues as Inhibitors of Mycobacterial Thymidylate Synthase X. [41] Computational analysis to investigate the anti-rheumatic potential of plant-based small molecule inhibitor targeting tumor necrosis factor . [42] Plasmodium falciparum PFI1625c offers an opportunity to design potent anti-malarials: Biochemical characterization and testing potentials in drug discovery. [43] Artificial Intelligence: A Novel Approach for Drug Discovery. [44] Hydrogen sulphide: novel opportunity for drug discovery. [45] Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery. [46] Scale, scope, and spillovers: the determinants of research productivity in drug discovery. [47] Correction: A study towards drug discovery for the management of type 2 diabetes mellitus through inhibition of the carbohydrate-hydrolyzing enzymes α-amylase and α-glucosidase by chalcone derivatives. [48] An overview of late-stage functionalization in today's drug discovery. [49] Molecular Networking As a Drug Discovery, Drug Metabolism, and Precision Medicine Strategy [50] Circadian biology and sleep in monogenic neurological disorders and its potential application in drug discovery [51] Paper spray mass spectrometry for drug analysis: an alternative to LC-MS/MS in forensic, clinical and drug discovery laboratories for dried blood spot samples [52] RNA therapeutics: Identification of novel targets leading to drug discovery. [53] Identification of a novel turn-on albumin binding small-molecule bioprobe in live zebrafish and its potential application in drug discovery [54] Multi-channel PINN: investigating scalable and transferable neural networks for drug discovery [55] A landmark in drug discovery based on complex natural product synthesis [56] AICD: an integrated anti-inflammatory compounds database for drug discovery [57] Tissue-specific genes as an underutilized resource in drug discovery [58] Machine learning-powered antibiotics phenotypic drug discovery [59] A critical evaluation of TRPA1-mediated locomotor behavior in zebrafish as a screening tool for novel anti-nociceptive drug discovery [60] Targeting HIV-1 Protease Autoprocessing for High-throughput Drug Discovery and Drug Resistance Assessment [61] STING modulators: Predictive significance in drug discovery [62] Engineered skeletal muscles for disease modeling and drug discovery [63] Contemporary Anti-Ebola Drug Discovery Approaches and Platforms [64] Drug discovery for chagas disease: A viewpoint [65] Nuclear Receptors: Recent Drug Discovery for Cancer Therapies [66] Unearthing fungal chemodiversity and prospects for drug discovery [67] Natural product derived privileged scaffolds in drug discovery [68] An outlook on using serial femtosecond crystallography in drug discovery [69] Cell death assays for neurodegenerative disease drug discovery [70] Chikungunya virus drug discovery: still a long way to go? [71] How can molecular micro-CT imaging revolutionize drug discovery? [72] Emerging Glycolysis Targeting and Drug Discovery from Chinese Medicine in Cancer Therapy [73] [Artificial Intelligence-based Drug Discovery and Drug Repositioning]. [74] Big Data and Artificial Intelligence Modeling for Drug Discovery. [75] Applications of Quantitative Systems Pharmacology in Model-Informed Drug Discovery: Perspective on Impact and Opportunities. [76] Globally Distributed Drug Discovery of New Antibiotics: Design and Combinatorial Synthesis of Amino Acid Derivatives in the Organic Chemistry Laboratory [77] Polyphenols targeting diabetes via the AMP-activated protein kinase pathway; future approach to drug discovery. [78] Challenges to drug discovery for celiac disease and approaches to overcome them [79] Latest advances in aging research and drug discovery. [80] Novel targets for drug discovery in celiac disease. [81] Pharmaceutical analysis combined with in-silico therapeutic and toxicological profiling on zileuton and its impurities to assist in modern drug discovery. [82] MID3: Mission Impossible or Model-Informed Drug Discovery and Development? Point-Counterpoint Discussions on Key Challenges. [83] Challenges in Alzheimer Disease Drug Discovery and Development: The Role of Modeling, Simulation and Open Data. [84] Meeting organometallic chemistry with drug discovery: CH activation enabled discovery of a new ring system of 12H-Indazolo[2,1-a]cinnolin-12-ones with anti-proliferation activity. [85] Secure multiparty computation for privacy-preserving drug discovery. [86] Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology. [87] Future challenges with DNA-encoded chemical libraries in the drug discovery domain. [88] Synthetic biology – reimagine drug discovery [89] Applications of machine learning in drug discovery and development. [90] De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery [91] Modeling heart failure in animal models for novel drug discovery and development [92] Learning from our failures in blood–brain permeability: what can be done for new drug discovery? [93] The successes and failures of HIV drug discovery [94] A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery [95] Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development [96] drug discovery: past and present [97] commentary on focus in antibiotics and drug discovery from streptomycesa commentary ontoward a new focus in antibiotic and drug discovery from streptomyces arsenalby antoraz s, santamaría ri, díaz m, sanz d and rodríguez h (2015). front. microbiol. 6:461.doi: 10.3389/fmicb.2015.00461 [98] drug delivery: enabling technology for drug discovery and development.iprecio® micro infusion pump: programmable, refillable and implantable [99] can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges [100] qsar-assisted virtual screening of lead-like molecules from marine and microbial natural sources for antitumor and antibiotic drug discovery [101] advanced cell culture techniques for cancer drug discovery